Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples